Research Topic · Peer-Reviewed

SARS-CoV-2

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the enveloped, positive-sense single-stranded RNA betacoronavirus that causes coronavirus disease 2019 (COVID-19), first identified in late 2019 and subsequently declared a global pandemic. It belongs to the family Coronaviridae and is closely related t…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 24× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the enveloped, positive-sense single-stranded RNA betacoronavirus that causes coronavirus disease 2019 (COVID-19), first identified in late 2019 and subsequently declared a global pandemic. It belongs to the family Coronaviridae and is closely related to the earlier SARS-CoV, sharing the characteristic crown-like array of surface spike (S) glycoproteins from which coronaviruses take their name. The spike protein mediates attachment to and entry into host cells and is a primary focus of vaccine and therapeutic development. The virus spreads chiefly through respiratory droplets and aerosols, and infection ranges from asymptomatic carriage to severe pneumonia and multi-organ involvement. Research on SARS-CoV-2 spans its molecular evolution and phylogenetic relationship to other human and animal coronaviruses through spike gene sequence analysis, the prediction and tracking of viral mutations, viral kinetics under candidate treatments, host immune and cytokine responses to the spike protein, transmissibility modelling across interacting populations, vaccination outcomes and adverse events, and convalescent-plasma neutralizing antibody approaches. The journal also publishes on the cellular pathogenesis of infected tissues, the zoonotic dimension linking animals to human infection, and candidate prophylactic and therapeutic strategies, reflecting the breadth of virological, clinical, and epidemiological study the topic encompasses.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538
2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
Exact topic International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on SARS-CoV-2, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.